Ulisse BioMed srl of Udine at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Ulisse BioMed srl

Viacavour 20, 33100 Udine

This company is co-exhibitor of
ARIES Società consortile a resp. limitata

Hall map

MEDICA 2019 hall map (Hall 16): stand B42

Fairground map

MEDICA 2019 fairground map: Hall 16

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.04  Other molecular diagnostics testing

Other molecular diagnostics testing

Our products

Product category: Other molecular diagnostics testing


Our first Sagitta application is LadyMed, a service providing the diagnosis of Human Papilloma Virus (HPV) infection which is known to cause cervical and other cancers types.

HPV diagnosis and genotyping is possible thanks to HPV Selfy proprietary chemistry, which is allowing to characterize 14 high risk HPV types starting from a simple swab-based sampling that can be performed by patients (self-sampling) or clinicians.

LadyMed is the first service which combines a unique simple consumer self-sampling and an hrHPV genotyping result that is delivered directly on consumer smartphone.

Our technology does not require DNA extraction allowing the analysis lab to reduce complexity and cost resulting in a faster more efficient process.

LadyMed is targeting the 8 million HPV women globally are at risk of developing cervical cancer caused by HPV. The HPV testing market is expected to grow at a rate of 10% per year over the next 5 years.

LadyMed screens for the presence of HPV and diagnose (high-risk) hrHPV at lower cost and greater scale than previously possible.

More Less

Product category: Other molecular diagnostics testing


Our technology has the unique ability to detect and perform the genotyping of the 14 most frequent high- risk (hrHPV) variants without any DNA extraction step.

This unprecedented technology based on SagittaTM platform reduces the complexity and cost of HPV testing and offers new pathways in diagnosis and treatment.

With this new platform, we can screen for the presence of HPV and diagnose hrHPV on a scale never thought possible.

Available as CE-IVD or RUO version. 

More Less

Product category: Other molecular diagnostics testing


NanOracle is our nanoswitch reader concept. Ulisse BioMed is currently collaborating with companies that are going to built our first prototype.
NanOracle is a simple and portable device which can be managed in ambulatory setting or at home. NanOracle is a common and simple reader that can be fluorescence based or electrochemical depending on the used Nanohybrid platform.

This strip/cartridge system is really user friendly and capable to give a simple readout within few minutes. Depending on the loaded strips is possible to use NanOracle for both diagnostic and theranostic purposes.

More Less

About us

Company details

Ulisse BioMed is an innovative StartUp active in healthcare

Founded in 2015, Ulisse BioMed is a global biotech Company with corporate offices in Udine, Italy and Lincolnshire, IL, and with R&D labs in Trieste, Italy and at the IHV (Institute of Human Virology) at the University of Maryland.

Ulisse BioMed is creating novel, innovative and transformative diagnostic platforms and products.

The Company mission and purpose for the science, technologies and products is to create new diagnostic modalities and care models in settings never thought possible throughout the world.

More Less